Kedudukan dalam Saham
#42474
PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments... PhaseRx, Inc. is a biopharmaceutical company dedicated to developing treatments for inherited enzyme deficiencies affecting the liver. Its therapeutic strategy involves intracellular enzyme replacement, powered by its unique Hybrid mRNA technology platform, which facilitates the production of absent enzymes directly within the body's cells. The company's pipeline includes several programs targeting urea cycle disorders, such as PRX-OTC for ornithine transcarbamylase deficiency, PRX-ASL for argininosuccinate lyase deficiency, and PRX-ASS1 for argininosuccinate synthetase deficiency. Established in 2006, PhaseRx is headquartered in Seattle, Washington.
Harga Saham
$0.0001
Disegerakkan terakhir: 2026-08-11
Perubahan (1 tahun)
0.00%
Perdagangan PhaseRx, Inc. (PZRXQ)
Harga PZRXQ dengan permodalan pasaran b
Modal pasaran bagi PhaseRx, Inc.(PZRXQ)
Modal Pasaran: $1.17K
Sehingga August 2026, PhaseRx, Inc. mempunyai modal pasaran sebanyak $1.17K. Ini menjadikan PhaseRx, Inc. syarikat ke-42474th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran PhaseRx, Inc. dari 2016 hingga 2026
PZRXQ berbanding dengan 5 teratas yang paling popular stocks
| Harga PZRXQ |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.426T
|
+464,168,840,447.48%
|
|
|
|
|
$4.426T
|
+378,617,171,037.73%
|
|
|
|
|
$4.159T
|
+355,751,159,202.91%
|
|
|
|
|
$3.663T
|
+313,308,663,886.31%
|
|
|
|
|
$2.892T
|
+247,381,085,150.73%
|
